Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr632 Inhibitors

Olfr632, a member of the olfactory receptor family, plays a pivotal role in the olfactory system, where it functions as a chemosensory receptor responsible for detecting specific odorant molecules. This receptor is expressed in olfactory sensory neurons located within the nasal epithelium, contributing to the intricate process of odor perception. The olfactory system relies on the activation of olfactory receptors, like Olfr632, by binding to odorant molecules, initiating a signaling cascade that eventually leads to the perception of the corresponding smell. Understanding the functional significance of Olfr632 in olfaction is crucial for unraveling the complexities of sensory perception and elucidating the intricate mechanisms governing odor recognition. Inhibition of Olfr632 involves targeted interference with the signaling pathways associated with its activation and downstream cellular responses. The identified inhibitors target specific molecular pathways, such as the VEGF, TGF-β, MAPK/ERK, PI3K/Akt, Bcr-Abl, c-Kit, and mTOR pathways, among others. These pathways are intricately involved in cellular processes that intersect with olfactory receptor signaling. For instance, inhibitors like Axitinib and Imatinib disrupt tyrosine kinase pathways, impacting cellular responses that may indirectly influence Olfr632 expression. Similarly, compounds like Wortmannin and LY294002 inhibit PI3K, a crucial enzyme in the PI3K/Akt pathway, potentially altering cellular responses associated with olfactory receptor activation. The modulation of MAPK/ERK signaling by inhibitors such as U0126 and Trametinib provides another avenue for indirectly influencing Olfr632 expression, given the role of this pathway in cellular processes.

Furthermore, the inhibitors mentioned, including SB-431542, Cisplatin, Dasatinib, Rapamycin, AZD8055, and SP600125, target diverse signaling pathways, each with its specific impact on cellular responses related to olfactory receptor function. This multi-targeted approach reflects the intricate network of molecular interactions governing olfaction, highlighting the complex interplay between different pathways in regulating the expression and activity of olfactory receptors like Olfr632. In summary, understanding the functional role of Olfr632 in the olfactory system and the intricacies of its inhibition involves a comprehensive analysis of the diverse molecular pathways that intersect with its signaling cascade, providing valuable insights into the complex landscape of odor perception at the molecular level.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB-431542 is a selective inhibitor of the TGF-β type I receptor, impacting the TGF-β signaling pathway. Disruption of this pathway may indirectly influence Olfr632 by modulating cellular responses mediated by TGF-β.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK1/2 inhibitor that disrupts the MAPK/ERK signaling pathway. Its action on this pathway may indirectly affect Olfr632 expression, as the MAPK pathway plays a role in regulating various cellular processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, targets the PI3K/Akt signaling pathway. Modulation of this pathway by Wortmannin could potentially impact Olfr632 expression by altering cellular responses mediated by PI3K.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin, a platinum-based chemotherapeutic, can induce DNA damage and activate p53. The p53 pathway modulation by Cisplatin may indirectly influence Olfr632 expression through its impact on cellular stress responses.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib, a tyrosine kinase inhibitor, targets the Bcr-Abl and c-Kit pathways. Its interference with these pathways may indirectly impact Olfr632 expression by altering cellular signaling cascades associated with these kinases.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, disrupts the PI3K/Akt pathway. Its action on this pathway may indirectly affect Olfr632 expression by modulating cellular responses mediated by PI3K.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a multi-kinase inhibitor targeting Bcr-Abl and Src family kinases. Its impact on these pathways may indirectly influence Olfr632 expression by altering cellular signaling cascades associated with these kinases.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, disrupts the mTOR signaling pathway. Modulation of this pathway by Rapamycin could potentially impact Olfr632 expression by altering cellular responses mediated by mTOR.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Trametinib is a MEK1/2 inhibitor that disrupts the MAPK/ERK signaling pathway. Its action on this pathway may indirectly affect Olfr632 expression, as the MAPK pathway plays a role in regulating various cellular processes.

AZD8055

1009298-09-2sc-364424
sc-364424A
10 mg
50 mg
$163.00
$352.00
12
(2)

AZD8055, an mTOR inhibitor, disrupts the mTOR signaling pathway. Modulation of this pathway by AZD8055 could potentially impact Olfr632 expression by altering cellular responses mediated by mTOR.